Impacting some signaling pathways like Wnt and β-catenin, and AKT/mTORC1 pathway, oncogenic factors (e.g., c-Myc) or apoptotic proteins, such as Bcl-2 can partly explain some mechanisms through which miR-184 may exert its role as a tumor suppressor (Table 1). The gene discussed is BCL2; the disease is neoplasm.